Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration

Biomaterials

Volumn 32, Issue 11, 2011, Pages 2797-2811

  Ratanavaraporn, Juthamas ^a   Furuya, Hiroyuki ^a   Kohara, Hiroshi ^a   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein 2 (BMP 2); Bone regeneration; Combined release; Gelatin hydrogels; Stromal cell derived factor 1 (SDF 1)

Indexed keywords

BONE MORPHOGENETIC PROTEIN-2; BONE REGENERATION; COMBINED RELEASE; GELATIN HYDROGELS; STROMAL CELLS;

BONE; GENE EXPRESSION; PROTEINS;

HYDROGELS;

BONE MORPHOGENETIC PROTEIN 2; CD31 ANTIGEN; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GELATIN; GREEN FLUORESCENT PROTEIN; OSTEOCALCIN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE MARROW CELL; BONE REGENERATION; BONE TISSUE; CONTROLLED STUDY; GENE EXPRESSION; HISTOPATHOLOGY; HYDROGEL; MESENCHYMAL STEM CELL; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; ULNA;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CELLS, CULTURED; CHEMOKINE CXCL12; CORE BINDING FACTOR ALPHA 1 SUBUNIT; FEMALE; FLOW CYTOMETRY; GELATIN; HYDROGELS; MALE; MICE; MICE, INBRED C57BL; OSTEOCALCIN; RATS; RATS, WISTAR; RECEPTORS, CXCR4; TISSUE ENGINEERING; X-RAY MICROTOMOGRAPHY;

MUS; RATTUS;

EID: 79951580452     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.12.052     Document Type: Article

References (59)

1. Langer R. Tissue engineering: perspectives, challenges and future directions. Tissue Eng 2007, 13:1-2.
2. Nedovic V., Willaret R. Applications of cell immobilization biotechnology 2005, Springer, The Netherlands.
3. Smith M.K., Peters M.C., Richardson T.P., Garbern J.C., Mooney D.J. Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng 2004, 10:63-71.
4. Seitz S., Ern K., Lamper G., Docheva D., Drosse I., Milz S., et al. Influence of in vitro cultivation on the integration of cell-matrix constructs after subcutaneous implantation. Tissue Eng 2007, 13:1059-1067.
5. Modo M., Rezaie P., Heuschling P., Patel S., Male D.K., Hodges H. Transplantation of neural stem cells in a rat model of stroke: assessment of short-term graft survival and acute host immunological response. Brain Res 2002, 958:70-82.
6. Wan C., He Q., Li G. Allogenic peripheral blood derived mesenchymal stem cells (MSCs) enhance bone regeneration in rabbit ulna critical-sized bone defect model. J Orthop Res 2006, 24:610-618.
7. Kuznetsov S.A., Mankani M.H., Gronthos S., Satomura K., Bianco P., Robey P.G. Circulating skeletal stem cells. J Cell Biol 2001, 153:1133-1139.
8. Otsuru S., Tamai K., Yamazaki T., Yoshikawa H., Kaneda Y. Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun 2007, 354:453-458.
9. Kimura Y., Miyazaki N., Hayashi N., Otsuru S., Tamai K., Kaneda Y., et al. Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue. Tissue Eng Part A 2010, 16:1263-1270.
10. Sordi V., Malosio M.L., Marchesi F., Mercalli A., Melzi R., Giordano T., et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005, 106:419-427.
11. Zhang G., Nakamura Y., Wang X., Hu Q., Suggs L.J., Zhang J. Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart. Tissue Eng 2007, 13:2063-2071.
12. Peled A., Petit I., Kollet O., Magid M., Ponomaryov T., Byk T., et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999, 283:845-848.
13. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864.
14. Aiuti A., Webb I.J., Bleul C., Springer T., Gutierrez-Ramos J.C. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997, 185:111-120.
15. Jin D.K., Shido K., Kopp H.G., Petit I., Shmelkov S.V., Young L.M., et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006, 12:557-567.
16. Zhou B., Han Z.C., Poon M.C., Pu W. Mesenchymal stem/stromal cells (MSC) transfected with stromal derived factor 1 (SDF-1) for therapeutic neovascularization: enhancement of cell recruitment and entrapment. Med Hypotheses 2007, 68:1268-1271.
17. Otsuru S., Tamai K., Yamazaki T., Yoshikawa H., Kaneda Y.A. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/ stromal cell-derived factor-1 pathway. Stem Cells 2008, 26:223-234.
18. Kimura Y., Tabata Y. Controlled release of stromal cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed 2010, 21:37-51.
19. Deckers M.M.L., van Bezooijen R.L., van der Horst G., Hoogendam J., van Der Bent C., Papapoulos S.E., et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. Endocrinology 2002, 143:1545-1553.
20. Wagner T.U. Bone morphogenetic protein signaling in stem cells- one signal, many consequences. FEBS J 2007, 274:2968-2976.
21. Bessa P.C., Pedro A.J., Klosch B., Nobre A., van Griensven M., Reis R.L., et al. Osteoinduction in human fat-derived stem cells by recombinant human bone morphogenetic protein-2 produced in Escherichia coli. Biotechnol Lett 2008, 30:15-21.
22. Bessa P.C., Casal M., Reis R.L. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regener Med 2008, 2:81-96.
23. Zhu W., Boachie-Adjei O., Rawlins B.A., Frenkel B., Boskey A.L., Ivashkiv L.B., et al. A novel regulatory role for stromal derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. J Biol Chem 2007, 282:18676-18685.
24. Hosogane N., Huang Z., Rawlins B.A., Liu X., Boachie-Adjei O., Boskey A.L., et al. Stromal derived factor-1 regulates bone morphogenetic protein 2-induced osteogenic differentiation of primary mesenchymal stem cells. Int J Biochem Cell Biol 2010, 42:1132-1141.
25. Kimura Y., Tabata Y. Experimental tissue regeneration by DDS technology of bio-signaling molecules. J Dermatol Sci 2007, 47:189-199.
26. Takahashi Y., Yamamoto M., Tabata Y. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and b-tricalcium phosphate. Biomaterials 2005, 26:3587-3596.
27. Ozeki M., Tabata Y. In vivo degradability of hydrogels prepared from different gelatins by various cross-linking methods. J Biomater Sci Polym Ed 2005, 16:549-561.
28. Virk M.S., Conduah A., Park S.H., Liu N., Sugiyama O., Cuomo A., et al. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model. Bone 2008, 42:921-931.
29. Hollinger J.O., Kleinschmidt J.C. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg 1990, 1:60-68.
30. Okabe M., Ikawa M., Kominami K., Nakanishi T., Nishimune Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett 1997, 407:313-319.
31. Dvorakova J., Hruba A., Velebny V., Kubala L. Isolation and characterization of mesenchymal stem cell population entrapped in bone marrow collection sets. Cell Biol Int 2008, 32:1116-1125.
32. Lee J.S., Bae J.W., Joung Y.K., Lee S.J., Han D.K., Park K.D. Controlled dual release of basic fibroblast growth factor and indomethacin from heparin-conjugated polymeric micelle. Int J Pharm 2008, 346:57-63.
33. Holland T.A., Tabata Y., Mikos A.G. Dual growth factor delivery from degradable oligo (poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 2005, 10:111-125.
34. Simmons C.A., Alsberg E., Hsiong S., Kim W.J., Mooney D.J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004, 35:562-569.
35. Alsberg E., Kong H.J., Hirano Y., Smith M.K., Albeiruti A., Mooney D.J. Regulating bone formation via controlled scaffold degradation. J Dent Res 2003, 82:903-908.
36. Thieme S., Ryser M., Gentsch M., Navratiel K., Brenner S., Stiehler M., et al. Stromal cell-derived factor-1α-directed chemoattraction of transiently CXCR4-overexpressing bone marrow stromal cells into functionalized three-dimensional biomimetic scaffolds. Tissue Eng Part C 2009, 15:687-696.
37. Hayakawa J., Migita M., Ueda T., Fukazawa R., Adachi K., Ooue Y., et al. Dextran sulfate and stromal cell derived factor-1 promote CXCR4 expression and improve bone marrow homing efficiency of infused hematopoietic stem cells. J Nippon Med Sch 2009, 76:198-208.
38. Tabata Y. Significance of release technology in tissue engineering. Drug Discov Today 2005, 10:1639-1646.
39. Ishii Y., Garriock R.J., Navetta A.M., Coughlin L.E., Mikawa T. BMP signals promote proepicardial protrusion necessary for recruitment of coronary vessel and epicardial progenitors to the heart. Dev Cell 2010, 19:307-316.
40. Bryan D., Walker K.B., Ferguson M., Thorpe R. Cytokine gene expression in a murine wound healing model. Cytokine 2005, 31:429-438.
41. Inai K., Norris R.A., Hoffman S., Markwald R.R., Sugi Y. BMP-2 induces cell migration and periostin expression during atrioventricular valvulogenesis. Dev Biol 2008, 315:383-396.
42. Marrony S., Bassilana F., Seuwen K., Keller H. Bone morphogenetic protein 2 induces placental growth factor in mesenchymal stem cells. Bone 2003, 33:426-433.
43. Maes C., Coenegrachts L., Stockmans I., Daci E., Luttun A., Petryk A., et al. Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. J Clin Invest 2006, 116:1230-1242.
44. Fiedler J., Leucht F., Waltenberger J., Dehio C., Brenner R.E. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. Biochem Biophys Res Commun 2005, 334:561-568.
45. Kleinheinz J., Stratmann U., Joos U., Wiesmann H.P. VEGF-activated angiogenesis during bone regeneration. J Oral Maxillofac Surg 2005, 63:1310-1316.
46. Bussolino F., Albini A., Camussi G., Presta M., Viglietto G., Ziche M., et al. Role of soluble mediators in angiogenesis. Eur J Cancer 1996, 32A:2401-2412.
47. Folkman J. Angiogenesis: an organizing principle for drug discovery. Nat Rev Drug Discov 2007, 6:273-286.
48. Salcedo R., Wasserman K., Young H.A., Grimm M.C., Howard O.M., Anver M.R., et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1. Am J Pathol 1999, 154:1125-1135.
49. Grunewald M., Avraham I., Dor Y., Bachar-Lustig E., Itin A., Yung S., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189.
50. Schantz J.T., Chim H., Whiteman M. Cell guidance in tissue engineering: SDF-1 mediates site-directed homing of mesenchymal stem cells within three-dimensional polycaprolactone scaffolds. Tissue Eng 2007, 13:2615-2624.
51. Thevenot P.T., Nair A.M., Shen J., Lotfi P., Ko C.Y., Tang L. The effect of incorporation of SDF-1α into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 2010, 31:3997-4008.
52. Bieniasza M., Oszajca K., Eusebio M., Kordiak J., Bartkowiak J., Szemraj J. The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients. Lung Cancer 2009, 66:319-326.
53. Gao Q., Tong W., Luria J.S., Wang Z., Nussenbaum B., Krebsbach P.H. Effects of bone morphogenetic protein-2 on proliferation and angiogenesis in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 2010, 39:266-271.
54. David L., Feige J.J., Bailly S. Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 2009, 20:203-212.
55. Langenfeld E.M., Bojnowski J., Perone J., Langenfeld J. Expression of bone morphogenetic proteins in human lung carcinomas. Ann Thorac Surg 2005, 80:1028-1032.
56. Langenfeld E.M., Langenfeld J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2004, 2:141-149.
57. Hollnagel A., Oehlmann V., Heymer J., Ruther U., Nordheim A. Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells. J Biol Chem 1999, 274:19838-19845.
58. Kozawa O., Matsuno H., Uematsu T. Involvement of p70 S6 kinase in bone morphogenetic protein signaling: vascular endothelial growth factor synthesis by bone morphogenetic protein-4 in osteoblasts. J Cell Biochem 2001, 81:430-436.
59. Cunningham N.S., Paralkarp V., Reddi A.H. Osteogenin and recombinant bone morphogenetic protein 2B are chemotactic for human monocytes and stimulate transforming growth factor beta 1 mRNA expression. Proc Natl Acad Sci U S A 1992, 89:11740-11744.